Aarhus University Seal / Aarhus Universitets segl

Anders Hammerich Riis

Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

To evaluate the impact of risk minimisation policies on the use of rosiglitazone-containing products and on glycaemic control among patients in Denmark and the UK.
Original languageEnglish
JournalBMJ Open
Volume3
Issue9
Pages (from-to)e003424
ISSN2044-6055
DOIs
Publication statusPublished - 2013

See relations at Aarhus University Citationformats

ID: 56880529